Getting closer to affective disorders: the role of CRH receptor systems
Depressive disorders are a leading cause of morbidity and mortality worldwide. Current antidepressant drugs targeting monoamine neurotransmitter systems have a delayed onset of action, and fewer than 50% of the patients attain complete remission after therapy with a single antidepressant. A large bo...
Gespeichert in:
| Veröffentlicht in: | Trends in molecular medicine 2004-08, Vol.10 (8), p.409-415 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 415 |
|---|---|
| container_issue | 8 |
| container_start_page | 409 |
| container_title | Trends in molecular medicine |
| container_volume | 10 |
| creator | Müller, Marianne B. Wurst, Wolfgang |
| description | Depressive disorders are a leading cause of morbidity and mortality worldwide. Current antidepressant drugs targeting monoamine neurotransmitter systems have a delayed onset of action, and fewer than 50% of the patients attain complete remission after therapy with a single antidepressant. A large body of preclinical and clinical evidence points to a key role of the corticotropin-releasing hormone (CRH) receptor 1 subtype (CRHR1) in mediating CRH-elicited effects in anxiety, depressive disorders and stress-associated pathologies. Genetic modification of CRHR1 function in mice by the use of conventional and conditional knockout strategies enables further analysis of specific elements in the CRH circuitry. The recent characterisation of several selective small-molecule CRHR1 antagonists offers new possibilities for the treatment of anxiety and depression. |
| doi_str_mv | 10.1016/j.molmed.2004.06.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66786705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1471491404001546</els_id><sourcerecordid>18028182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-fed882a1f9d50a70d5402385417342b6df35af3beb8525edf1f69f255e1aa99f3</originalsourceid><addsrcrecordid>eNqFkF1LIzEUhoOs-FH9B4vkau86nmSSTMYLYSlrFQRBFLwL6eTETZlpapIK_fc7pcVL9-ocOM_7HngI-cmgYsDU9bIaYj-gqziAqEBVAM0ROWOiYVPRtm8_vnYmTsl5zksAJptGn5BTJmsGQvEzMp9jKWH1Trs-Zky0RGq9x66ET6Qu5JgcpnxDy1-kKfZIo6ez53uasMN1iYnmbS445Aty7G2f8fIwJ-T17s_L7H76-DR_mP1-nHa1bsvUo9OaW-ZbJ8E24KQAXmspWFMLvlDO19L6eoELLblE55lXredSIrO2bX09Ib_2vesUPzaYixlC7rDv7QrjJhulGq0akP8FmQaumeYjKPZgl2LOCb1ZpzDYtDUMzM60WZq9abMzbUCZ0fQYuzr0bxa721fooHYEbvcAjjo-AyaTu4CrDl0Y5RXjYvj-wz9A5JDM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18028182</pqid></control><display><type>article</type><title>Getting closer to affective disorders: the role of CRH receptor systems</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Müller, Marianne B. ; Wurst, Wolfgang</creator><creatorcontrib>Müller, Marianne B. ; Wurst, Wolfgang</creatorcontrib><description>Depressive disorders are a leading cause of morbidity and mortality worldwide. Current antidepressant drugs targeting monoamine neurotransmitter systems have a delayed onset of action, and fewer than 50% of the patients attain complete remission after therapy with a single antidepressant. A large body of preclinical and clinical evidence points to a key role of the corticotropin-releasing hormone (CRH) receptor 1 subtype (CRHR1) in mediating CRH-elicited effects in anxiety, depressive disorders and stress-associated pathologies. Genetic modification of CRHR1 function in mice by the use of conventional and conditional knockout strategies enables further analysis of specific elements in the CRH circuitry. The recent characterisation of several selective small-molecule CRHR1 antagonists offers new possibilities for the treatment of anxiety and depression.</description><identifier>ISSN: 1471-4914</identifier><identifier>EISSN: 1471-499X</identifier><identifier>DOI: 10.1016/j.molmed.2004.06.007</identifier><identifier>PMID: 15310462</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Anxiety Disorders - drug therapy ; Anxiety Disorders - genetics ; Anxiety Disorders - pathology ; Corticotropin-Releasing Hormone - metabolism ; Depressive Disorder - drug therapy ; Humans ; Mice ; Mice, Knockout ; Peptide Fragments - therapeutic use ; Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors ; Receptors, Corticotropin-Releasing Hormone - physiology ; Stress Disorders, Traumatic - drug therapy ; Stress Disorders, Traumatic - genetics ; Stress Disorders, Traumatic - pathology</subject><ispartof>Trends in molecular medicine, 2004-08, Vol.10 (8), p.409-415</ispartof><rights>2004 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-fed882a1f9d50a70d5402385417342b6df35af3beb8525edf1f69f255e1aa99f3</citedby><cites>FETCH-LOGICAL-c389t-fed882a1f9d50a70d5402385417342b6df35af3beb8525edf1f69f255e1aa99f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.molmed.2004.06.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15310462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Müller, Marianne B.</creatorcontrib><creatorcontrib>Wurst, Wolfgang</creatorcontrib><title>Getting closer to affective disorders: the role of CRH receptor systems</title><title>Trends in molecular medicine</title><addtitle>Trends Mol Med</addtitle><description>Depressive disorders are a leading cause of morbidity and mortality worldwide. Current antidepressant drugs targeting monoamine neurotransmitter systems have a delayed onset of action, and fewer than 50% of the patients attain complete remission after therapy with a single antidepressant. A large body of preclinical and clinical evidence points to a key role of the corticotropin-releasing hormone (CRH) receptor 1 subtype (CRHR1) in mediating CRH-elicited effects in anxiety, depressive disorders and stress-associated pathologies. Genetic modification of CRHR1 function in mice by the use of conventional and conditional knockout strategies enables further analysis of specific elements in the CRH circuitry. The recent characterisation of several selective small-molecule CRHR1 antagonists offers new possibilities for the treatment of anxiety and depression.</description><subject>Animals</subject><subject>Anxiety Disorders - drug therapy</subject><subject>Anxiety Disorders - genetics</subject><subject>Anxiety Disorders - pathology</subject><subject>Corticotropin-Releasing Hormone - metabolism</subject><subject>Depressive Disorder - drug therapy</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Peptide Fragments - therapeutic use</subject><subject>Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors</subject><subject>Receptors, Corticotropin-Releasing Hormone - physiology</subject><subject>Stress Disorders, Traumatic - drug therapy</subject><subject>Stress Disorders, Traumatic - genetics</subject><subject>Stress Disorders, Traumatic - pathology</subject><issn>1471-4914</issn><issn>1471-499X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LIzEUhoOs-FH9B4vkau86nmSSTMYLYSlrFQRBFLwL6eTETZlpapIK_fc7pcVL9-ocOM_7HngI-cmgYsDU9bIaYj-gqziAqEBVAM0ROWOiYVPRtm8_vnYmTsl5zksAJptGn5BTJmsGQvEzMp9jKWH1Trs-Zky0RGq9x66ET6Qu5JgcpnxDy1-kKfZIo6ez53uasMN1iYnmbS445Aty7G2f8fIwJ-T17s_L7H76-DR_mP1-nHa1bsvUo9OaW-ZbJ8E24KQAXmspWFMLvlDO19L6eoELLblE55lXredSIrO2bX09Ib_2vesUPzaYixlC7rDv7QrjJhulGq0akP8FmQaumeYjKPZgl2LOCb1ZpzDYtDUMzM60WZq9abMzbUCZ0fQYuzr0bxa721fooHYEbvcAjjo-AyaTu4CrDl0Y5RXjYvj-wz9A5JDM</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Müller, Marianne B.</creator><creator>Wurst, Wolfgang</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Getting closer to affective disorders: the role of CRH receptor systems</title><author>Müller, Marianne B. ; Wurst, Wolfgang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-fed882a1f9d50a70d5402385417342b6df35af3beb8525edf1f69f255e1aa99f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Anxiety Disorders - drug therapy</topic><topic>Anxiety Disorders - genetics</topic><topic>Anxiety Disorders - pathology</topic><topic>Corticotropin-Releasing Hormone - metabolism</topic><topic>Depressive Disorder - drug therapy</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Peptide Fragments - therapeutic use</topic><topic>Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors</topic><topic>Receptors, Corticotropin-Releasing Hormone - physiology</topic><topic>Stress Disorders, Traumatic - drug therapy</topic><topic>Stress Disorders, Traumatic - genetics</topic><topic>Stress Disorders, Traumatic - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Müller, Marianne B.</creatorcontrib><creatorcontrib>Wurst, Wolfgang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Müller, Marianne B.</au><au>Wurst, Wolfgang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Getting closer to affective disorders: the role of CRH receptor systems</atitle><jtitle>Trends in molecular medicine</jtitle><addtitle>Trends Mol Med</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>10</volume><issue>8</issue><spage>409</spage><epage>415</epage><pages>409-415</pages><issn>1471-4914</issn><eissn>1471-499X</eissn><abstract>Depressive disorders are a leading cause of morbidity and mortality worldwide. Current antidepressant drugs targeting monoamine neurotransmitter systems have a delayed onset of action, and fewer than 50% of the patients attain complete remission after therapy with a single antidepressant. A large body of preclinical and clinical evidence points to a key role of the corticotropin-releasing hormone (CRH) receptor 1 subtype (CRHR1) in mediating CRH-elicited effects in anxiety, depressive disorders and stress-associated pathologies. Genetic modification of CRHR1 function in mice by the use of conventional and conditional knockout strategies enables further analysis of specific elements in the CRH circuitry. The recent characterisation of several selective small-molecule CRHR1 antagonists offers new possibilities for the treatment of anxiety and depression.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>15310462</pmid><doi>10.1016/j.molmed.2004.06.007</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1471-4914 |
| ispartof | Trends in molecular medicine, 2004-08, Vol.10 (8), p.409-415 |
| issn | 1471-4914 1471-499X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66786705 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Animals Anxiety Disorders - drug therapy Anxiety Disorders - genetics Anxiety Disorders - pathology Corticotropin-Releasing Hormone - metabolism Depressive Disorder - drug therapy Humans Mice Mice, Knockout Peptide Fragments - therapeutic use Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors Receptors, Corticotropin-Releasing Hormone - physiology Stress Disorders, Traumatic - drug therapy Stress Disorders, Traumatic - genetics Stress Disorders, Traumatic - pathology |
| title | Getting closer to affective disorders: the role of CRH receptor systems |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T15%3A35%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Getting%20closer%20to%20affective%20disorders:%20the%20role%20of%20CRH%20receptor%20systems&rft.jtitle=Trends%20in%20molecular%20medicine&rft.au=M%C3%BCller,%20Marianne%20B.&rft.date=2004-08-01&rft.volume=10&rft.issue=8&rft.spage=409&rft.epage=415&rft.pages=409-415&rft.issn=1471-4914&rft.eissn=1471-499X&rft_id=info:doi/10.1016/j.molmed.2004.06.007&rft_dat=%3Cproquest_cross%3E18028182%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18028182&rft_id=info:pmid/15310462&rft_els_id=S1471491404001546&rfr_iscdi=true |